Overview
Ti-Com is a Contract Research Organization that specializes in preclinical research using large animal models to test drugs and medical devices for central nervous system diseases. They utilize image-guided procedures, particularly an endovascular model of stroke in pigs, to enhance precision in testing biomarkers, diagnostics, and therapeutic agents. Their services include project logistics management and behavioral testing to support the development of new treatments.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
SNOSSA Meeting 2024
The 7th Annual Meeting of the Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA) was held in Harare, the capital of Zimbabwe, from July 25 to 27, 2024.
SIGN Meeting 2024
Early in 2024, the Society for Image-Guided Neurointerventions (SIGN) held its conference in the stunning and exotic Ramoji Film City, just outside Hyderabad,
Ti-com Seeks Investment at Invest Cuffs 2023 in Krakow
Ti-com seeks investment at Invest Cuffs in Cracow. It is the biggest business conference in Poland, at a spectacular ICE Congress Centre.
SIGN Meeting 2022
Two weeks ago we had the opportunity to be part of an incredibly interesting conference Society for Image-Guided Neurointerventions (SIGN) in the
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-12-10. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 2, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Olsztyn |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-01-01 | 101183041 - Engvipo - engineering vascularized implants for personalised osteochondral tissue regeneration: from medical imaging to pre-clinical validation | $114.3K$114,283 | 1.0.11 - Horizon Europe |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The persons authorised to make declarations of will in property and non-property matters and to sign on behalf of the company are: in the event of a one-person management board – a member of the management board independently; in the event of a multi-member management board – two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dominika Gołubczyk (34) | 39 | $526.74 | 19.5% |
Mirosław Janowski (51) | 80 | $1,080.50 | 40% |
Piotr Walczak (50) | 75 | $1,012.97 | 37.5% |
Others | 6 | $81.04 | 3% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-08-24 | Share capital change (5,000.00 PLN → 10,000.00 PLN) | |
| 2018-07-23 | Entered in the register |
FAQ
Last updated: 2026-04-02